NanoVibronix Inc NAOV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NAOV is a good fit for your portfolio.
News
-
NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024
-
NanoVibronix Issues Letter to Stockholders
-
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
-
Thinking about buying stock in Intuitive Machines, SoundHound AI, Interactive Strength, Altimmune, or NanoVibronix?
Trading Information
- Previous Close Price
- $0.77
- Day Range
- $0.75–0.77
- 52-Week Range
- $0.70–4.34
- Bid/Ask
- $0.75 / $0.85
- Market Cap
- $2.09 Mil
- Volume/Avg
- 8,660 / 57,141
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.57
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.nanovibronix.com
Valuation
|
Metric
|
NAOV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.38 |
Price/Sales | 0.57 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NAOV
|
|---|---|
Quick Ratio | 1.51 |
Current Ratio | 2.64 |
Interest Coverage | −26.27 |
Quick Ratio
NAOV
Profitability
|
Metric
|
NAOV
|
|---|---|
Return on Assets (Normalized) | −60.90% |
Return on Equity (Normalized) | −113.81% |
Return on Invested Capital (Normalized) | −108.92% |
Return on Assets
NAOV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Vjqslsz | Ljhxch | $185.5 Bil | |
SYK
| Stryker Corp | Rsplmcgxsm | Wwlb | $128.2 Bil | |
MDT
| Medtronic PLC | Bjgqkvyc | Gnlyyk | $106.7 Bil | |
BSX
| Boston Scientific Corp | Drpprrwlm | Cpjmhd | $99.0 Bil | |
DXCM
| DexCom Inc | Zrcclczfvm | Mfrp | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Hzsgnvxsmn | Wxlbyf | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ftqsckljmf | Mglm | $24.9 Bil | |
ALGN
| Align Technology Inc | Nnfcywdm | Sdmjfc | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Tjhttzdfd | Kkllp | $18.9 Bil | |
PODD
| Insulet Corp | Tbmczfyx | Nzckc | $11.7 Bil |